Atlas Trials

Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children

Clinical trial NCT04158310 · UNKNOWN

Trial details

NCT number
NCT04158310
Sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Community Acquired Pneumonia
Start date
2019-11-11
Primary completion
2020-12-01
Enrollment
9207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.